Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy (ICASH)
The utilization of external cardiohemodynamic patient assessment, applying non-invasive stick-on contact patches to the mother's neck on either side and chest wall on either side, enables the practitioner to have information about the patient's cardiac function and vascular status beyond simply blood pressure and pulse. This information, once collected, should open the practitioner's eyes to better assess the patient's disease status and her response to therapy. We will use this information to compare the effectiveness of the two standard medications used for treatment of maternal high blood pressure.
Pregnancy; Proteinuria, With Hypertension (Severe Pre-eclampsia)
Delivery; Proteinuria, With Gestational Hypertension (Pre-eclampsia, Severe)
Pregnancy; Hypertension, Gestational Hypertension, With Albuminuria (Severe Pre-eclampsia)
|Study Design:||Time Perspective: Prospective|
|Official Title:||Impedance Cardiographic Assessment of Gravidas With Severe Hypertension (ICASH)to Assess Impact of Standard Therapy on Hemodynamic Parameters - A Pilot Study|
- Usefulness of Impedance Cardiography (ICG) in pregnant women with hypertension [ Time Frame: 36 ] [ Designated as safety issue: No ]ICG test is performed on pregnant women before receiving any antihypertensive medication. Labetalol and Hydralazine, two ot the most commonly used antihypertensives to treat high blood pressure in pregnant women will be used in this study.
Biospecimen Retention: Samples Without DNA
One tube of blood
|Study Start Date:||December 2009|
|Estimated Study Completion Date:||February 2013|
|Estimated Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|
This group will receive administration of the antihypertensive Hydralazine for the attempted control of their blood pressure and stabilization of their hemodynamic state.
This group will receive administration of the antihypertensive Labetalol for the attempted control of their blood pressure and stabilization of their hemodynamic state.
Pregnant patients with severe acute hypertension due either to superimposed preeclampsia, severe preeclampsia or severe gestational hypertension will be randomized to receive either of two antihypertensive agents (hydralazine or labetalol). Just before drug administration and immediately thereafter impedance cardiography of the patient will be undertaken and the results analyzed relative to the cardiac profile and the drug administered to reduce the severe hypertension.
|United States, Mississippi|
|Wiser Hospital for Women and Infants at the University of Mississippi Medical Center||Recruiting|
|Jackson, Mississippi, United States, 39216|
|Contact: Sheila K Belk firstname.lastname@example.org|
|Principal Investigator: James N. Martin, Jr., MD|
|Sub-Investigator: Rick W. Martin, MD|
|Sub-Investigator: Michelle Y. Owens, MD|
|Sub-Investigator: James A. Bofill, MD|
|Sub-Investigator: Birdie B. LaMarca, PhD|
|Sub-Investigator: Pushpinder Dhillon, MD|
|Sub-Investigator: Sara Richards, MD|
|Sub-Investigator: Justin Brewer, MD|
|Principal Investigator:||James N Martin, MD||SOM-Obstetrics & Gynecology|